AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23584092 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG) with left ventricular reconstruction
Number of subjects: 1232
Study 23584092 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 1232
Study 22195358 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg/day for 3 weeks, then 10 mg/day)
Number of subjects: 79
Study 22195358 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (100 mg/day)
Number of subjects: 79
Study 22195358 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 79
Study 22195358 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 79
Study 19758285 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (G1) - informed treatment
Number of subjects: 123
Study 19758285 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (G2) - informed possible active drug or placebo
Number of subjects: 123
Study 19758285 — intervention group
Group type: COMPARATOR
Intervention: Group 3 (G3) - aware of placebo
Number of subjects: 123
Study 16798186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-saving device
Number of subjects: 40
Study 16798186 — intervention group
Group type: COMPARATOR
Intervention: Control (standard closed venous reservoir)
Number of subjects: 40
Study 12735550 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 232
Study 12735550 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical control
Number of subjects: 232
Study 11122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 0
Study 9302064 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ vein grafts
Number of subjects: 91
Study 9302064 — intervention group
Group type: COMPARATOR
Intervention: Reversed vein grafts
Number of subjects: 91
Study 8335580 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (ET) - 60 min of cycling, 3 days/week, at 60% VO2max for 10 weeks
Number of subjects: 13
Study 8335580 — intervention group
Group type: COMPARATOR
Intervention: Control group (UT) - no exercise training
Number of subjects: 13
Study 3278232 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (15 mg per week)
Number of subjects: 14
Study 3278232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29631553 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week oral estrogen replacement (combination of ethinyl estradiol 0.03 mg and dienogest 2 mg)
Number of subjects: 0
Study 29631553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28608971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (Research participation)
Number of subjects: 20
Study 28608971 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo arm)
Number of subjects: 20
Study 25654108 — intervention group
Group type: EXPERIMENTAL
Intervention: OND + APREP
Number of subjects: 98
Study 25654108 — intervention group
Group type: COMPARATOR
Intervention: OND
Number of subjects: 98
Study 23113757 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions intervention
Number of subjects: 956
Study 23113757 — intervention group
Group type: COMPARATOR
Intervention: Mere measurement condition
Number of subjects: 956
Study 21966519 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2mA)
Number of subjects: 11
Study 21966519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2mA)
Number of subjects: 11
Study 21966519 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 11
Study 18343373 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant LH 75 IU/day
Number of subjects: 20
Study 18343373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16873437 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic oligosaccharides (0.8 g/100 ml)
Number of subjects: 259
Study 16873437 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrine)
Number of subjects: 259
Study 16873437 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic oligosaccharides
Number of subjects: 259
Study 12493644 — intervention group
Group type: EXPERIMENTAL
Intervention: Sighs added during ventilation in prone position
Number of subjects: 10
Study 12493644 — intervention group
Group type: EXPERIMENTAL
Intervention: Sighs added during ventilation in supine position
Number of subjects: 10
Study 12493644 — intervention group
Group type: COMPARATOR
Intervention: Control group (ventilation without sighs) in prone position
Number of subjects: 10
Study 12493644 — intervention group
Group type: COMPARATOR
Intervention: Control group (ventilation without sighs) in supine position
Number of subjects: 10
Study 10786231 — intervention group
Group type: EXPERIMENTAL
Intervention: Victims of political persecution (PTSD)
Number of subjects: 30
Study 10786231 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 8755837 — intervention group
Group type: COMPARATOR
Intervention: Hemodialyzed patients
Number of subjects: 48
Study 8755837 — intervention group
Group type: COMPARATOR
Intervention: Hemodialyzed patients (on the day of dialysis and on the following day)
Number of subjects: 48
Study 8755837 — intervention group
Group type: COMPARATOR
Intervention: Non-dialyzed and hemodialyzed uremic patients
Number of subjects: 48
Study 8755837 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 48
Study 1899550 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC + UFT
Number of subjects: 86
Study 1899550 — intervention group
Group type: COMPARATOR
Intervention: MMC only (group A)
Number of subjects: 86
Study 6284720 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 30
Study 6284720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31789451 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg)
Number of subjects: 24
Study 31789451 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice)
Number of subjects: 24
Study 31789451 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin (5 mg)
Number of subjects: 24
Study 31789451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29952672 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex strength training
Number of subjects: 28
Study 27487300 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week MBSR bibliotherapy intervention
Number of subjects: 92
Study 27487300 — intervention group
Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 92
Study 25554233 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced REP
Number of subjects: 1531
Study 25554233 — intervention group
Group type: COMPARATOR
Intervention: Standard REP
Number of subjects: 1531
Study 24292313 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 44
Study 24292313 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone (control)
Number of subjects: 44
Study 20970963 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PVP-I solution (Arakeri's iodine solution)
Number of subjects: 50
Study 20970963 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study 19920268 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based decision-support system (10 centers, 753 patients)
Number of subjects: 2866
Study 19920268 — intervention group
Group type: COMPARATOR
Intervention: Paper guidelines (posters and pocket cards) (10 centers, 1015 patients)
Number of subjects: 2866
Study 18219779 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric electrical stimulation (GES)
Number of subjects: 12
Study 18219779 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 15789981 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate 360 degrees toothbrush
Number of subjects: 80
Study 15789981 — intervention group
Group type: COMPARATOR
Intervention: Oral‐B CrossAction toothbrush
Number of subjects: 80
Study 14564895 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg)
Number of subjects: 16
Study 14564895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 14564895 — intervention group
Group type: COMPARATOR
Intervention: Bright light exposure (> 3000 lux)
Number of subjects: 16
Study 14564895 — intervention group
Group type: COMPARATOR
Intervention: Dim light exposure (< 10 lux)
Number of subjects: 16
Study 9709290 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer screening (mammograms)
Number of subjects: 1000
Study 7935276 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A as retinol palmitate (300,000 UI a day for the first year and 150,000 UI for the second year)
Number of subjects: 29
Study 7935276 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg a day for two years)
Number of subjects: 29
Study 7935276 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vitamin A and N-acetylcysteine
Number of subjects: 29
Study 7935276 — intervention group
Group type: COMPARATOR
Intervention: No drugs (control group)
Number of subjects: 29
Study 3060232 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% hydroxypropyl methylcellulose
Number of subjects: 84
Study 3060232 — intervention group
Group type: COMPARATOR
Intervention: 1% sodium hyaluronate
Number of subjects: 84
Study 30629306 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing therapy program initiated within 1 year post-radiotherapy
Number of subjects: 117
Study 30629306 — intervention group
Group type: COMPARATOR
Intervention: Swallowing therapy program initiated after 2 years post-radiotherapy
Number of subjects: 117
Study 29208991 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS (20 mins)
Number of subjects: 50
Study 29208991 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS (40 seconds)
Number of subjects: 50
Study 25176002 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT) at home
Number of subjects: 19
Study 25176002 — intervention group
Group type: COMPARATOR
Intervention: 6-minute walk test (6MWT) at hospital
Number of subjects: 19
Study 25176002 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter track length at home
Number of subjects: 19
Study 25176002 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased number of turns during home test
Number of subjects: 19
Study 23255685 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally-prepared ready-to-use therapeutic food (LRUTF)
Number of subjects: 98
Study 23255685 — intervention group
Group type: COMPARATOR
Intervention: Locally-prepared F100 diet
Number of subjects: 98
Study 20828829 — intervention group
Group type: EXPERIMENTAL
Intervention: iStent trabecular micro‐bypass stent with cataract surgery
Number of subjects: 240
Study 20828829 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery only
Number of subjects: 240
Study 18006861 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical gait trainer (GT)
Number of subjects: 54
Study 18006861 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical gait trainer with functional electrical stimulation (GT-FES)
Number of subjects: 54
Study 18006861 — intervention group
Group type: COMPARATOR
Intervention: Conventional overground gait training (CT)
Number of subjects: 54
Study 16539086 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy
Number of subjects: 2793
Study 16539086 — intervention group
Group type: COMPARATOR
Intervention: No perioperative chemotherapy
Number of subjects: 2793
Study 14610121 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal allele at codon 171
Number of subjects: 100
Study 14610121 — intervention group
Group type: EXPERIMENTAL
Intervention: Asn171Ser variant allele
Number of subjects: 100
Study 10993427 — intervention group
Group type: EXPERIMENTAL
Intervention: Water load test in dysmotility‐like functional dyspepsia patients
Number of subjects: 48
Study 10993427 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric dysrhythmias in dysmotility‐like functional dyspepsia patients
Number of subjects: 48
Study 10993427 — intervention group
Group type: COMPARATOR
Intervention: Gastric dysrhythmias in control subjects
Number of subjects: 48
Study 10993427 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproducibility of gastric myoelectrical activity
Number of subjects: 48
Study 8790128 — intervention group
Group type: EXPERIMENTAL
Intervention: Centers for Disease Control and Prevention lead screening questionnaire
Number of subjects: 2978
Study 8790128 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete questionnaire used in Denver
Number of subjects: 2978
Study 8790128 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lead levels greater than 0.96 mumol/L (20 micrograms/dL)
Number of subjects: 2978
Study 8790128 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lead levels greater than 0.48 mumol/L (10 micrograms/dL)
Number of subjects: 2978
Study 1644087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg twice daily)
Number of subjects: 17
Study 1644087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 6433495 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA enriched solution containing 50% of amino acids as BCAA
Number of subjects: 5
Study 6433495 — intervention group
Group type: COMPARATOR
Intervention: Complete feeding solution containing 15.6% of amino acids as BCAA
Number of subjects: 5
Study 30500967 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (AZI)
Number of subjects: 613
Study 30500967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study 30208157 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 102
Study 30208157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 30208157 — intervention group
Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 102
Study 26269149 — intervention group
Group type: EXPERIMENTAL
Intervention: Military body armour (BA)
Number of subjects: 0
Study 26269149 — intervention group
Group type: COMPARATOR
Intervention: No body armour (BA)
Number of subjects: 0
Study 24901876 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral vertebroplasty (VP)
Number of subjects: 39
Study 24901876 — intervention group
Group type: COMPARATOR
Intervention: Bilateral vertebroplasty (VP)
Number of subjects: 39
Study 22430337 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal eosinophilia test
Number of subjects: 100
Study 22430337 — intervention group
Group type: COMPARATOR
Intervention: Control group (no allergic rhinitis)
Number of subjects: 100
Study 20082618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with hydrolysed infant formulas (partially or extensively hydrolysed whey, extensively hydrolysed casein (eHF-C), or standard cow's milk formula)
Number of subjects: 5991
Study 20082618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with eHF-C formula
Number of subjects: 5991
Study 20082618 — intervention group
Group type: COMPARATOR
Intervention: Non-interventional group (children without familial predisposition)
Number of subjects: 5991
Study 18725223 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition, wide-angle endoscope (HDE)
Number of subjects: 693
Study 18725223 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope (SC)
Number of subjects: 693
Study 15505639 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in and around the GAD1 gene
Number of subjects: 72
Study 15505639 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-SNP haplotypes
Number of subjects: 72
Study 15505639 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs
Number of subjects: 72
Study 12929894 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH intervention schools
Number of subjects: 76
Study 12929894 — intervention group
Group type: COMPARATOR
Intervention: CATCH control schools
Number of subjects: 76
Study 12929894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both school conditions
Number of subjects: 76
Study 9805537 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg furosemide
Number of subjects: 21
Study 9805537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 8533565 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygroscopic tent
Number of subjects: 0
Study 8533565 — intervention group
Group type: COMPARATOR
Intervention: Gemeprost
Number of subjects: 0
Study 8533565 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (administered orally 17 hours before vacuum curettage)
Number of subjects: 0
Study 8533565 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (administered orally 10 hours before vacuum curettage)
Number of subjects: 0
Study 2376102 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% zinc citrate/silica product
Number of subjects: 187
Study 2376102 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest Tartar Control
Number of subjects: 187
Study 2376102 — intervention group
Group type: COMPARATOR
Intervention: Crest Regular
Number of subjects: 187
Study 74197 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvinyl alcohol 5%
Number of subjects: 22
Study 74197 — intervention group
Group type: COMPARATOR
Intervention: Liquid paraffin
Number of subjects: 22
Study 74197 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose bengal scoring (modified Bijsterveld method)
Number of subjects: 22
Study 31436109 — intervention group
Group type: EXPERIMENTAL
Intervention: Water immersion during the first stage of labor
Number of subjects: 64
Study 31436109 — intervention group
Group type: COMPARATOR
Intervention: Not submerged (control group)
Number of subjects: 64
Study 30293352 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1.0 μg/kg, followed by continuous infusion of 0.5 μg·kg(‐1)·h(‐1) until 20 min before the end of operation)
Number of subjects: 120
Study 30293352 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 120
Study 28237612 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (800mg/day)
Number of subjects: 49
Study 28237612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 26200118 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoliosis-specific exercises (SSE) with a home exercise plan
Number of subjects: 58
Study 26200118 — intervention group
Group type: COMPARATOR
Intervention: Standard practice of advice and education
Number of subjects: 58
Study 26200118 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoliosis-specific exercises (SSE)
Number of subjects: 58
Study 23085116 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise treatment (GET)
Number of subjects: 151
Study 23085116 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy (UP)
Number of subjects: 151
Study 21389329 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fluid (TDF) sampling following acute plyometric exercise
Number of subjects: 22
Study 21389329 — intervention group
Group type: COMPARATOR
Intervention: Transdermal fluid (TDF) sampling following 60 min of cycling exercise at 60% Vo(2)(peak)
Number of subjects: 22
Study 18513462 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (0.5-2.0 mg/day)
Number of subjects: 320
Study 18513462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 17161727 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography to age 48 years
Number of subjects: 160921
Study 17161727 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 160921
Study 14570652 — intervention group
Group type: COMPARATOR
Intervention: IV saline 5 mL (Group I)
Number of subjects: 90
Study 14570652 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of IV pantoprazole (Group II)
Number of subjects: 90
Study 14570652 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of IV ranitidine (Group III)
Number of subjects: 90
Study 11218969 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 92
Study 11218969 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg/day
Number of subjects: 92
Study 11218969 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of Atorvastatin
Number of subjects: 92
Study 9778713 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration
Number of subjects: 40
Study 9778713 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 8310975 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily
Number of subjects: 16
Study 8310975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2458198 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (2 x 2 mg)
Number of subjects: 6
Study 2458198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 1563131 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with propranolol 20 mg tid and diltiazem 60 mg tid
Number of subjects: 13
Study 362831 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. L-tryptophan
Number of subjects: 20
Study 362831 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 31767788 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavoured WP tobacco
Number of subjects: 144
Study 31767788 — intervention group
Group type: COMPARATOR
Intervention: Non-flavoured WP tobacco
Number of subjects: 144
Study 31295165 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT (Substance Use Screening, Brief Intervention, and Referral to Treatment)
Number of subjects: 0
Study 28323804 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertl procedure
Number of subjects: 2
Study 28323804 — intervention group
Group type: COMPARATOR
Intervention: Burgess procedure
Number of subjects: 2
Study 25441594 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral refeeding (EORF)
Number of subjects: 146
Study 25441594 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral refeeding (CORF)
Number of subjects: 146
Study 25022371 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified oral brush biopsy
Number of subjects: 225
Study 25022371 — intervention group
Group type: COMPARATOR
Intervention: Exfoliative cytology
Number of subjects: 225